RELN and Alzheimer disease: Thus, in APOE ε3/ε3 subjects, the 420 kDa full-length reelin decreased in AD (51%, p < 0.001) compared to the NDC subgroup; the decrease was also significant when compared to APOE ε3/ε4 subjects (36%, p = 0.002).